TSLA
Tesla
-- 436.170 MU
Micron Technology
-- 87.090 NVDA
NVIDIA
-- 130.680 QUBT
Quantum Computing
-- 15.140 AMD
Advanced Micro Devices
-- 118.880 
🟢 Watchlist FRIDAY December 20,2024. N F A ! …. In progress
NOTE!
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits
5. Always remember shorts include dark pools.
6. Most importantly, don’t blame for your losses. I already give watchlist and stock education. The ball is on you.
7. I DO NOT give buy or sell advice
8. COH (cash on hand); AH (after hours): RTH (regular trading hours)
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits
5. Always remember shorts include dark pools.
6. Most importantly, don’t blame for your losses. I already give watchlist and stock education. The ball is on you.
7. I DO NOT give buy or sell advice
8. COH (cash on hand); AH (after hours): RTH (regular trading hours)
$Aadi Biosciences (AADI.US)$ PR AH 12/19: Aadi Enters Agreement to Sell FYARRO® and Associated Infrastructure to KAKEN Pharmaceutical for $100M; Announces PIPE Financing of $100M. COH $49.3M good for 10 months. Cumulative Capital Expected to Fund Operations into Late 2028. No dilution risk.
$Nvni Group (NVNI.US)$ No PR but ran whole day until AH. History: Received staff determination letter on Nov 12.2024 due to non compliance with listing requirement of timely filing of Form 20-F. NVNI filed appeal Nov 15 which automatically stays suspension for 15 days (until Nov 30). The company also intended to request an extended stay while appeal is in process. Low float. May still rock tomorrow. 0 shares LTB. COH $0.7M. High risk for dilution.
$Lumen Technologies (LUMN.US)$ PR 12/19: Launches sale of consumer fiber unit, sources say. Valued at $7-$10B. Huge float. No dilution risk.
$BioAge Labs (BIOA.US)$ PRs 2 consecutive days: 12/19 Global license agreement with Bristol Myers Squibb for BioArctic's PyroGlutamate-amyloid-beta antibody program where BioArctic will receive a USD 100 million upfront payment and up to USD 1.25 billion in milestone payments: 12/18: Multi-Year Collaboration With Novartis To Discover Novel Targets For Therapies That Address Age-Related Diseases And Conditions; Novartis To Pay Up To $20M Comprising Upfront Payments And Research Funding; BioAge May Receive Up To $530M In Future Long-Term Research, Development, And Commercial Milestones. Hasn’t gained much traction. This for me is just waiting to rally. Low float. No dilution history. Caution.
$Xilio Therapeutics (XLO.US)$ PR 12/19 AH: 13G Gilead Sciences Acquires 7.85M Xilio Therapeutics Shares At $1.04 Each, Raising Ownership To Over 10%, Along With 6.1M Pre-Funded Warrants Capped At 19.99% Ownership. Low float. COH $61.8M
$Mission Produce (AVO.US)$ PR 12/19 AH Good ER. No dilution risk
$Imunon (IMNN.US)$ PR 12/19: Positive CMC Meeting with FDA for IMNN-001 in Treatment of Advanced Ovarian Cancer. Low float. COH $6M good for 3.7 months
$Aptose Biosciences (APTO.US)$ PR 12/19 AH: Listing extension granted. This ran AH but since it’s AH, may still get traction tomorrow. COH $7.1M good for 3.1 months
$Avita Medical (RCEL.US)$ PR 12/19 AH: FDA 510(k) clearance for Cohealyx™, a new collagen-based dermal matrix designed for tissue integration and revascularization to facilitate wound healing, reduce treatment timelines, and improve patient outcomes in the treatment of full-thickness wounds. COH $32.2M good for 7.1 months
$Prestige Wealth (PWM.US)$ PR AH 12/19: Regained listing compliance. China low float stock. High risk for dilution
$Innovative Solutions and Support (ISSC.US)$ PR AH 12/19: Good ER. COH $1.78M
$Mangoceuticals (MGRX.US)$ PR AH 12/19: Completes Acquisition of Mushroom-Based Wellness and Innovations Patent. Low float. No cash on hand. HIGH risk for dilution.
$Modular Medical (MODD.US)$ PR AH 12/19: Announces Licensing and Partnership Agreement With Nudge BG to bring to market an adaptive full closed loop Automated Insulin Delivery system that does not require mealtime announcements. COH $8.3M good for 6.8 months
$VivoPower (VVPR.US)$ PR AH 12/19: Filed its Form 20F deficiency. Wait for compliance announcement. SI 17.76%. COH $60K. HIGH risk for dilution.
$Avinger (AVGR.US)$ PR AH 12/19: Notice of Allowance for Patent Catheter device with detachable distal end for treatment of peripheral artery disease. Low float. No cash on hand. HIGH risk for dilution
$Lumen Technologies (LUMN.US)$ PR 12/19: Launches sale of consumer fiber unit, sources say. Valued at $7-$10B. Huge float. No dilution risk.
$BioAge Labs (BIOA.US)$ PRs 2 consecutive days: 12/19 Global license agreement with Bristol Myers Squibb for BioArctic's PyroGlutamate-amyloid-beta antibody program where BioArctic will receive a USD 100 million upfront payment and up to USD 1.25 billion in milestone payments: 12/18: Multi-Year Collaboration With Novartis To Discover Novel Targets For Therapies That Address Age-Related Diseases And Conditions; Novartis To Pay Up To $20M Comprising Upfront Payments And Research Funding; BioAge May Receive Up To $530M In Future Long-Term Research, Development, And Commercial Milestones. Hasn’t gained much traction. This for me is just waiting to rally. Low float. No dilution history. Caution.
$Xilio Therapeutics (XLO.US)$ PR 12/19 AH: 13G Gilead Sciences Acquires 7.85M Xilio Therapeutics Shares At $1.04 Each, Raising Ownership To Over 10%, Along With 6.1M Pre-Funded Warrants Capped At 19.99% Ownership. Low float. COH $61.8M
$Mission Produce (AVO.US)$ PR 12/19 AH Good ER. No dilution risk
$Imunon (IMNN.US)$ PR 12/19: Positive CMC Meeting with FDA for IMNN-001 in Treatment of Advanced Ovarian Cancer. Low float. COH $6M good for 3.7 months
$Aptose Biosciences (APTO.US)$ PR 12/19 AH: Listing extension granted. This ran AH but since it’s AH, may still get traction tomorrow. COH $7.1M good for 3.1 months
$Avita Medical (RCEL.US)$ PR 12/19 AH: FDA 510(k) clearance for Cohealyx™, a new collagen-based dermal matrix designed for tissue integration and revascularization to facilitate wound healing, reduce treatment timelines, and improve patient outcomes in the treatment of full-thickness wounds. COH $32.2M good for 7.1 months
$Prestige Wealth (PWM.US)$ PR AH 12/19: Regained listing compliance. China low float stock. High risk for dilution
$Innovative Solutions and Support (ISSC.US)$ PR AH 12/19: Good ER. COH $1.78M
$Mangoceuticals (MGRX.US)$ PR AH 12/19: Completes Acquisition of Mushroom-Based Wellness and Innovations Patent. Low float. No cash on hand. HIGH risk for dilution.
$Modular Medical (MODD.US)$ PR AH 12/19: Announces Licensing and Partnership Agreement With Nudge BG to bring to market an adaptive full closed loop Automated Insulin Delivery system that does not require mealtime announcements. COH $8.3M good for 6.8 months
$VivoPower (VVPR.US)$ PR AH 12/19: Filed its Form 20F deficiency. Wait for compliance announcement. SI 17.76%. COH $60K. HIGH risk for dilution.
$Avinger (AVGR.US)$ PR AH 12/19: Notice of Allowance for Patent Catheter device with detachable distal end for treatment of peripheral artery disease. Low float. No cash on hand. HIGH risk for dilution
$Psyence Biomedical (PBM.US)$ PR 12/19: Granted limited, exclusive, worldwide, royalty-bearing rights to specified psilocybin products for use in clinical trials and therapeutic applications in designated fields of use. Ran today but I feel this still has steam. Just crossed VWAP AH. Low float. 0 shares LTB. COH $1.9M good for 7.9 months
$AleAnna (ANNA.US)$ PR 12/19: Signing of Gas Sale Contract with Shell Energy Europe. Low float. COH $30.1M good for 60.8 months
$AleAnna (ANNA.US)$ PR 12/19: Signing of Gas Sale Contract with Shell Energy Europe. Low float. COH $30.1M good for 60.8 months
$Personalis (PSNL.US)$ PR 12/19: Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna. COH $132.4M
$Ondas Holdings (ONDS.US)$ PR 12/19: One of the World's Largest Semiconductor Manufacturers Renews Its Contract with Ondas' Airobotics for Drone Aerial Security and Data Services. COH $14.4 good for 5.1 months
$Knightscope (KSCP.US)$ PR 12/19: Closed 12 new contracts in 7 U.S. states for its K1B Emergency Communication Devices ("ECDs") and related services. KSCP is a company innovator in robotics and artificial intelligence ("AI") technologies. COH $11.5M good for 5.9 months
$VCI Global (VCIG.US)$ PR 12/19: Embarks on a Strategic Series of Renewable Energy Asset Acquisitions, Starting with a North Macedonia Solar Farm valued at $1.6M.
$Ondas Holdings (ONDS.US)$ PR 12/19: One of the World's Largest Semiconductor Manufacturers Renews Its Contract with Ondas' Airobotics for Drone Aerial Security and Data Services. COH $14.4 good for 5.1 months
$Knightscope (KSCP.US)$ PR 12/19: Closed 12 new contracts in 7 U.S. states for its K1B Emergency Communication Devices ("ECDs") and related services. KSCP is a company innovator in robotics and artificial intelligence ("AI") technologies. COH $11.5M good for 5.9 months
$VCI Global (VCIG.US)$ PR 12/19: Embarks on a Strategic Series of Renewable Energy Asset Acquisitions, Starting with a North Macedonia Solar Farm valued at $1.6M.
$Tonix Pharmaceuticals (TNXP.US)$ PR 12/17: FDA accepted NDA for treatment of fibromyalgia. COH $19.3M good for 3.8 months May still get traction tomorrow. Price crossed VWAP AH with good volume
$Wearable Devices (WLDS.US)$ PR 12/17: Wearable Devices and RayNeo Unveil First Neural-Controlled AR Glasses at CES 2025, Serving as the Catalyst for Strategic Collaborations and OEM Integrations. Low float. SI 13.28%, CTB 295%. COH $5.1M good for 8 months.
$Wearable Devices (WLDS.US)$ PR 12/17: Wearable Devices and RayNeo Unveil First Neural-Controlled AR Glasses at CES 2025, Serving as the Catalyst for Strategic Collaborations and OEM Integrations. Low float. SI 13.28%, CTB 295%. COH $5.1M good for 8 months.
$Tivic Health Systems (TIVC.US)$ No PR. Possible DCB. Low float COH $1.7M good for 3.6 months. Mentioned to me by my brother @Trytosaveabit 😉
$Tevogen Bio Holdings (TVGN.US)$ PR 12/19: Strengthens Robust IP Portfolio With Filing of Predictive AI Patent. Low float. No cash on hand. HIGH risk for dilution.
$DevvStream (DEVS.US)$ PR 12/19: Launches Carbon Offset Sales Initiative Targeting Corporations and Consumers. Low float. COH $2.1M good for 13.2 months
$Banzai International (BNZI.US)$ PR 12/19: Completes Acquisition of OpenReel, Expects to Exceed $10.0 Million 2024 Revenue Guidance. Low float. COH $2.6M good for 4.4 months
$VSee Health (VSEE.US)$ PR 12/19: Secures Teleradiology Contract With Major Post-Acute Care Hospital System, Launching In Q1 2025 With Potential $1.5M Annual Revenue. Take note it had another PR 12/18: Awarded teleradiology services agreement with Premier who handles 2/3 of US medical providers. Low float. CTB 475%. COH $1.5M good for 4.7 months
$DevvStream (DEVS.US)$ PR 12/19: Launches Carbon Offset Sales Initiative Targeting Corporations and Consumers. Low float. COH $2.1M good for 13.2 months
$Banzai International (BNZI.US)$ PR 12/19: Completes Acquisition of OpenReel, Expects to Exceed $10.0 Million 2024 Revenue Guidance. Low float. COH $2.6M good for 4.4 months
$VSee Health (VSEE.US)$ PR 12/19: Secures Teleradiology Contract With Major Post-Acute Care Hospital System, Launching In Q1 2025 With Potential $1.5M Annual Revenue. Take note it had another PR 12/18: Awarded teleradiology services agreement with Premier who handles 2/3 of US medical providers. Low float. CTB 475%. COH $1.5M good for 4.7 months
$HeartSciences (HSCS.US)$ No PR today, Up AH but PR 12/18: Maxim group reiterates buy rating with price target of 12; and 12/17 Withdrew registration or offering. Microfloat. COH $2.2M
good for 3.1 months
$Lexicon Pharmaceuticals (LXRX.US)$ Upcoming PDUFA decision tomorrow regarding their NDA application for Zynquista, a medication as adjunct to insulin therapy for glycemic control for patients with Type 1 DM and CKD. Previously CRL received after The Advisory Committee voted 11 to 3 that the benefits of Zynquista do not outweigh the risks in adults with T1D and CKD. SI 14.26%. COH $211M good for 12.1 months
$Kaixin Holdings (KXIN.US)$ No PR up AH. China Low float. SI 15.04%. COH No cash. HIGH risk for dilution.
good for 3.1 months
$Lexicon Pharmaceuticals (LXRX.US)$ Upcoming PDUFA decision tomorrow regarding their NDA application for Zynquista, a medication as adjunct to insulin therapy for glycemic control for patients with Type 1 DM and CKD. Previously CRL received after The Advisory Committee voted 11 to 3 that the benefits of Zynquista do not outweigh the risks in adults with T1D and CKD. SI 14.26%. COH $211M good for 12.1 months
$Kaixin Holdings (KXIN.US)$ No PR up AH. China Low float. SI 15.04%. COH No cash. HIGH risk for dilution.
$Quantum BioPharma (QNTM.US)$ No PR up AH. Either pumped or upcoming PR. Low float. COH $6.3M good for 9.4 months
$WiMi Hologram Cloud (WIMI.US)$ WIMI PR 12/19: Announces The Research Of A New Quantum Algorithm, The Holographic Quantum Linear Solver, Aiming To Provide A More Efficient And Resource-Efficient Quantum Algorithm For Solving The Quantum Linear System Problem; PR 12/18: Develops New Design Solution For Simulating Quantum Computing Concepts Using FPGA. China stock. COH $10.5Mz Quantum play
$ABVC BioPharma (ABVC.US)$ PR 12/19 Revolutionize Mental Health Treatment with a safe Prozac alternative of which Prozac has been discontinued in the market. ABVC holds patents for MDD and ADHD good until 2041. Low float.
$Snow Lake Resources (LITM.US)$ Up after hours. PR today prospectus on sale of common shares. So caution on trading this- scale out. Low float. COH $9.6M
$Graphex Group (GRFX.US)$ Possible LITM sympathy play. No cash on hand. HIGH risk for dilution. China stock
$Palatin Technologies (PTN.US)$ PR 12/19: Positive data from BREAKOUT study for patients with diabetic nephropathy. Up AH. Low float. No cash on hand. HIGH risk for dilution.
$SEALSQ Corp (LAES.US)$ PRs 12/19: 13G 8.5% and closed public offering. May gain traction tomorrow. SI 14.22%. COH $67M good for 37 months.
*******************************************
POSSIBLE DELISTING PLAY
$Molecular Templates (MTEM.US)$ December 26
$American Lithium (AMLI.US)$ December 27
$Molecular Templates (MTEM.US)$ December 26
$American Lithium (AMLI.US)$ December 27
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
152258659 : Hello from Australia Mate, Thanks for your valuable input. Cheers
HannChau :![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
i was not able to invest US stock anymore until January 2024 as i break my country FEP limit ![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
I can only watch now ![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Jaguar8 OP HannChau : Oh
Bellaah : Are you on twitter or Stocktwits
Jaguar8 OP Bellaah : None. Why?
mikem85 :
Jaguar8 OP mikem85 : Yup. It can cause volatility. It may also result to a gamma squeeze depending on the stock which has options
Dazzlingtheworld : thank you,
Zoriannn HannChau : what's the FEP limit in your country?
HannChau Zoriannn : 1 million local currency, around 210k USD
View more comments...